Breast Cancer Clinical Trial
Official title:
Effects of Expressive Writing in Breast Cancer Survivors With Lymphedema
RATIONALE: Expressive writing may help relieve symptoms and improve quality of life in
breast cancer survivors with chronic lymphedema.
PURPOSE: This clinical trial is studying expressive writing in improving the quality of life
in women with breast cancer and lymphedema.
OBJECTIVES:
Primary
- To determine if expressive writing improves quality of life (QOL) relative to the
control condition in breast cancer survivors with chronic stage II lymphedema.
- To determine if expressive writing improves physical and psychological
symptoms/outcomes (i.e., fatigue, psychological distress, activity level, confidence in
body) relative to the control condition in breast cancer survivors with chronic
lymphedema.
Secondary
- To explore the influence of individual difference variables (dispositional optimism,
emotional intelligence, and repressive coping) on outcomes associated with this
intervention to include identification of subsets of individuals for whom expressive
writing is most effective.
- To explore the influence of intrusive/avoidant thinking as a mediator between the
intervention and outcomes of QOL and physical and psychological symptoms.
OUTLINE: Patients are randomized to 1 of 2 treatment groups.
Patients travel to the School of Nursing at Vanderbilt University or meet a team member in
their home or another private location for an initial visit. Patients complete
questionnaires, are measured for height and weight data, and arm fluid measurements.
- Expressive writing group: Twenty minutes a day, twice a week for 2 weeks, patients
write about their deepest thoughts and feelings regarding their lymphedema and its
treatment.
- Daily diary group (control): Twenty minutes a day, twice a week for 2 weeks patients
write about how they manage their time .
Patients complete quality-of-life questionnaires periodically.
After completion of study, patients are followed at 1, 3, and 6 months.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |